ADMA Biologics to Participate in Raymond James Institutional Investor Conference

NEXT STORY
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
PREV STORY
Cullinan Management, Inc. Announces Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MediWound Strengthens its NexoBrid European Presence with Additional Distribution Agreements

author_avatar
NASDAQ Market News

Kalytera Announces Formation of Strategic and Scientific Advisory Board to Assist with Development of Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain

SAN FRANCISCO and TEL AVIV, Israel, May 15, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, ...

author_avatar
NASDAQ Market News

bioAffinity Technologies Announces Formation of Scientific and Medical Advisory Board; M. Patricia Rivera, MD, Joins Board as Chair

author_avatar
NASDAQ Market News